Cargando…
Molecular Epidemiological Study of Pyrazinamide-Resistance in Clinical Isolates of Mycobacterium tuberculosis from South India
Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemotherapy against Mycobacterium tuberculosis. In this study, PCR mediated automated DNA sequencing is used to check the prevalence of PZA resistance among treatment failure cases of pulmonary tuberculosis...
Autores principales: | Muthaiah, Muthuraj, Jagadeesan, Sridharan, Ayalusamy, Nisha, Sreenivasan, Manupriya, Prabhu, Sambamurthy Sangamesvara, Muthuraj, Usharani, Senthilkumar, Kamatchiyammal, Veerappan, Saroja |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920559/ https://www.ncbi.nlm.nih.gov/pubmed/20717529 http://dx.doi.org/10.3390/ijms11072670 |
Ejemplares similares
-
Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates
por: Muthaiah, Muthuraj, et al.
Publicado: (2017) -
Prevalence and factors associated with multidrug-resistant tuberculosis in South India
por: Shivekar, Smita S., et al.
Publicado: (2020) -
Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India
por: Krishnakumariamma, Krishnapriya, et al.
Publicado: (2020) -
Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes
por: Vidyaraj, C.K., et al.
Publicado: (2017) -
Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
por: Werngren, Jim, et al.
Publicado: (2021)